EmStop begins CAPTURE-2 trial of embolic protection system
EmStop has commenced the CAPTURE-2 investigational device exemption (IDE) clinical trial, assessing its embolic protection system during transcatheter aortic valve…
EmStop has commenced the CAPTURE-2 investigational device exemption (IDE) clinical trial, assessing its embolic protection system during transcatheter aortic valve…
Boston Scientific has announced a $1.5bn investment to acquire approximately a 34% equity stake in MiRus, a company developing the…
Embecta has completed its acquisition of UK-based medical device manufacturer Owen Mumford Holdings in a deal valued at up to…
PainTEQ has announced the commercial launch of TRAQ, an implant developed for posterior sacroiliac (SI) joint fusion, in the US.…
Butterfly Medical has raised $21m in Series C funding for the development and potential commercialisation of its minimally invasive device…
Ardent Health has partnered with Fujifilm Healthcare to bring Synapse enterprise imaging solutions to its acute care hospitals across six…
AngioDynamics has reported two-year findings from the PRESERVE pivotal trial, showing durable outcomes for the NanoKnife irreversible electroporation (IRE) system…
Revvity has received clearance from the US Food and Drug Administration (FDA) for its total testosterone automated chemiluminescence immunoassay (ChLIA)…
Johnson & Johnson (J&J) has globally launched its Shockwave C2 Aero coronary IVL catheter, developed to improve deliverability, lesion crossing,…
Roche has secured CE mark for the Elecsys pTau217 blood test, developed alongside Eli Lilly, for detecting Alzheimer's disease pathology.…